Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diagnostic criteria in terminating therapy in Basedow hyperthyroidism].

E Ogris1

  • 1Nuklearmedizinischen Abteilung des KH der Stadt Wien-Lainz.

Acta Medica Austriaca
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PP2A<sup>Rts1</sup> antagonizes Rck2-mediated hyperosmotic stress signaling in yeast.

Microbiological research·2022
Same author

Spontaneous changes in tumour cell dissemination to bone marrow in colorectal cancer.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009
Same author

Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2009
Same author

Advancements in the diagnosis of acute appendicitis in children and adolescents.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie·2005
Same author

[Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors].

Acta medica Austriaca. Supplement·2003
Same author

[Immunocytochemical and molecular detection of minimal residual disease in blood and bone marrow in colorectal cancer].

Acta medica Austriaca. Supplement·2003

Predicting long-term remission in Graves disease requires evaluating thyroid feedback mechanisms and immune markers. Normalizing TSH-receptor antibodies and specific HLA status indicate sustained remission after antithyroid drug therapy.

Area of Science:

  • Endocrinology
  • Immunology

Context:

  • Graves disease, an autoimmune disorder, causes hyperthyroidism via thyroid-stimulating antibodies.
  • Disease course is marked by remissions and exacerbations, necessitating controlled long-term therapy.

Purpose:

  • To establish criteria for evaluating remission during treatment and predicting sustained remission or recurrence after antithyroid drug therapy.
  • To differentiate between tests assessing thyroid feedback mechanisms and those examining underlying immune phenomena.

Summary:

  • Thyroid feedback tests include Thyroid suppression test and TRH-stimulation test (primarily for antithyroid monotherapy).
  • Immune marker tests include TSH-receptor antibody (TRAK), Thyroglobulin antibody (TAK), and microsomal antibody (MAK) tests.
  • HLA status is crucial for therapeutic decisions; positive tests predict long-term remission.

Related Experiment Videos

Impact:

  • Identifies key diagnostic markers for predicting long-term remission in Graves disease patients.
  • Aids clinicians in making informed therapeutic decisions and managing patient outcomes effectively.
  • Contributes to a better understanding of the immunopathogenesis of Graves disease and its treatment response.